【摘要】：目的：分析總結(jié)我科對(duì)兒童肝母細(xì)胞瘤的治療效果,探討影響肝母細(xì)胞瘤患兒預(yù)后的因素及治療經(jīng)驗(yàn)。 方法：回顧性分析我科2001-2011共10年間收治的20例肝母細(xì)胞瘤患兒的臨床資料,追蹤隨訪其生存狀況并對(duì)其進(jìn)行生存分析、Kaplan-Meier單因素分析。 結(jié)果：20例肝母細(xì)胞瘤患兒中,中位隨訪時(shí)間為39個(gè)月(1～114個(gè)月)。其中14例無瘤存活,4例死亡,2例失訪。19例行手術(shù)治療,1例未行手術(shù)。規(guī)律化療14例,不規(guī)律化療6例。2年生存率為83.33%,5年生存率為76.84%。 Kaplan-Meier單因素分析提示：影響肝母細(xì)胞瘤患兒預(yù)后的因素為年齡、病理分型、腫瘤能否根治性切除及術(shù)后2個(gè)月AFP是否降至正常水平,而性別、腫瘤PRETEXT分期、是否行術(shù)前化療并不是影響HB預(yù)后的因素。 結(jié)論：1、年齡、病理分型、腫瘤能否根治性切除、術(shù)后2個(gè)月AFP是否降至正常水平可能為影響肝母細(xì)胞瘤預(yù)后的因素：年齡較大、病理分型為上皮型、腫瘤根治性切除、術(shù)后2個(gè)月AFP降至正常水平的患兒生存時(shí)間較長(zhǎng)；2、在本中心的技術(shù)水平下,結(jié)合化療并且可以行根治性手術(shù)的患兒,治療效果較好。
[Abstract]:Objective: to analyze and summarize the therapeutic effect of our department on hepatoblastoma in children, and to explore the prognostic factors and treatment experience of children with hepatoblastoma. Methods: the clinical data of 20 cases of hepatoblastoma treated in our department from 2001 to 2011 were analyzed retrospectively. The survival status of 20 children with hepatoblastoma was followed up and the survival was analyzed by Kaplan-Meier single factor analysis. Results: the median follow-up time was 39 months (1 ~ 114 months) in 20 children with hepatoblastoma. Among them, 14 cases survived without tumor, 4 cases died, 2 cases lost visit, 19 cases were treated surgically, and 1 case was not operated. There were 14 cases of regular chemotherapy and 6 cases of irregular chemotherapy. The 2-year survival rate was 83.33 and the 5-year survival rate was 76.84%. Univariate analysis of Kaplan-Meier indicated that age, pathological type, radical resection of the tumor and whether AFP decreased to normal level 2 months after operation were the main factors influencing prognosis of hepatoblastoma children, while sex and PRETEXT stage of tumor were the main factors influencing the prognosis of children with hepatoblastoma. Preoperative chemotherapy is not a factor affecting the prognosis of HB. Conclusion: 1. Age, pathological type, radical resection of the tumor, and whether the AFP decreased to a normal level 2 months after operation may be the factors influencing the prognosis of hepatoblastoma: age, pathological type, epithelial type, radical resection of the tumor. The survival time of children with AFP decreased to normal level 2 months after operation was longer. 2. At the technical level of the center, the children who combine chemotherapy and can undergo radical operation have good therapeutic effect.
【學(xué)位授予單位】：廣西醫(yī)科大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2012
【分類號(hào)】：R735.7

【參考文獻(xiàn)】

相關(guān)期刊論文 前4條

1 魏艇;楊體泉;羅意革;董淳強(qiáng);;14例兒童肝母細(xì)胞瘤綜合治療的療效觀察[J];中國(guó)當(dāng)代兒科雜志;2009年06期

2 潘慈;湯靜燕;陳靜;薛惠良;董璐;周敏;江華;葉啟東;顧龍君;;14例肝母細(xì)胞瘤患兒的臨床療效觀察[J];中國(guó)當(dāng)代兒科雜志;2009年08期

3 徐敏;陳其民;湯靜燕;潘慈;;多學(xué)科協(xié)作模式診斷治療兒童肝母細(xì)胞瘤[J];實(shí)用兒科臨床雜志;2008年11期

4 謝勇;龍光輝;劉曉平;周曉初;鐘立明;;肝母細(xì)胞瘤的綜合治療及影響預(yù)后的因素評(píng)價(jià)[J];實(shí)用兒科臨床雜志;2008年11期

，

本文編號(hào)：2359964